LGVN (STOCKS)
Longeveron Inc. Common Stock
$1.137400
-0.022600 (-1.95%)
Prev close: $1.160000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Stephen H. Willard
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $25.83M
- Employees
- 25
- P/E (TTM)
- -0.86
- P/B (TTM)
- 4.69
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $1.44M |
| Benefits Costs and Expenses | $0.00 |
| Cost Of Revenue | $361.00K |
| Costs And Expenses | $23.61M |
| Gross Profit | $1.08M |
| Nonoperating Income/Loss | $828.00K |
| Operating Expenses | $23.25M |
| Depreciation and Amortization | $1.19M |
| Research and Development | $11.31M |
| Other Operating Expenses | $10.75M |
| Operating Income/Loss | -$22.17M |
| Income/Loss From Continuing Operations After Tax | -$21.34M |
| Income/Loss From Continuing Operations Before Tax | $1.44M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$21.34M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$21.34M |
| Net Income/Loss Available To Common Stockholders, Basic | -$21.34M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.98 |
| Diluted Earnings Per Share | -$0.98 |
| Basic Average Shares | 17,963,434,000 |
| Diluted Average Shares | 17,963,434,000 |
| Assets | $15.56M |
| Current Assets | $10.34M |
| Noncurrent Assets | $5.22M |
| Fixed Assets | $2.12M |
| Intangible Assets | $2.31M |
| Other Non-current Assets | $786.00K |
| Liabilities | $5.59M |
| Current Liabilities | $4.94M |
| Accounts Payable | $1.08M |
| Other Current Liabilities | $3.86M |
| Noncurrent Liabilities | $651.00K |
| Equity | $9.97M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $9.97M |
| Liabilities And Equity | $15.56M |
| Net Cash Flow From Operating Activities | -$16.72M |
| Net Cash Flow From Operating Activities, Continuing | -$16.72M |
| Net Cash Flow From Investing Activities | -$654.00K |
| Net Cash Flow From Investing Activities, Continuing | -$654.00K |
| Net Cash Flow From Financing Activities | $3.84M |
| Net Cash Flow From Financing Activities, Continuing | $3.84M |
| Net Cash Flow | -$13.53M |
| Net Cash Flow, Continuing | -$13.53M |
| Comprehensive Income/Loss | -$21.34M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$21.34M |
| Other Comprehensive Income/Loss | -$5.37M |